Prevalence of cervical human papillomavirus in Taiwanese women

Clinical and Investigative Medicine

Volumn 28, Issue 5, 2005, Pages 261-266

  Jeng, Cherng Jye ^a,b,c   Ko, Ma Lee ^a   Ling, Qing Dong ^a,b   Shen, Jenta ^d   Lin, Hui Wen ^a   Tzeng, Chii Ruey ^c   Ho, Chih Ming ^a,b   Chien, Tsai Yen ^a   Chen, Su Chee ^a  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CONDOM; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN TISSUE; INDUCED ABORTION; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; ORAL CONTRACEPTION; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; TAIWAN; UTERINE CERVICITIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VAGINAL DELIVERY; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; TAIWAN;

EID: 26944460386     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiology Rev 2003;16:1-17.
2. Department of Health, Executive Yuan, Taiwan, ROC. Statistics Report. Main Cause of Death from Cancer, for Female, Taiwan Area (1993-2002); 2002.
3. An HJ, Cho NH, Lee SY, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 2003;97:1672-80.
4. Cho NH, An HJ, Jeong JK, et al. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis. Am J Obstet Gynecol 2003;188:56-62.
5. Choi BS, Kim O, Park MS, et al. Genital human papillomavirus genotyping by HPV Oligonucleotide microarray in Korean commercial sex workers. J Med Virol 2003;71:41-5.
6. Kim CJ, Jeong JK, Park M, Park TS, et al. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol 2003;89:210-7.
7. Huang TS, Jeong JK, Park M, et al. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol Oncol 2003;90:51-6.
8. Lee SA, Kang D, Seo SS, et al. Multiple HPV infection in cervical cancer screened by HPV DNA chip. Cancer Let 2003;198:187-92.
9. Sun CA, Liu JF, Wu DM, et al. TY. Viral load of high-risk human papillomavirus, in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet 2002;76:41-7.
10. Ho GY, Bierman R, Beardsley LNP, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Eng J Med 1998;338:423-7.
11. Wang PD, Lin RS. Risk factors for cervical epithelial neoplasia in Taiwan. Gynecol Oncol 1996;62:10-8.
12. Sasagawa T, Basha W, Yamazaki H, Inoue M. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidem Biomark 2001;10:45-52.
13. Hsieh CY, You SL, Kao CL, Chen CJ. Reproductive and infectious risk factors for invasive cervical cancer in Taiwan. Anticancer Res 1999;19:4495-500.
14. Guiliano AR, Papenfuss M, Abrahamsen M, et al. Human papillomavirus infection at the United States-Mexico border. Cancer Epidem Biomark 2001;10:1129-36.
15. Cavalcanti SMB, Zardo LG, Passos MRL, Oliveira LHS. Epidemiological aspects of human papillomavirus infection and cervical cancerin Brazil. J Infect 2000;40:80-7.
16. Claeys P, Gonzalez C, Gonzalez M, Van Renterghem L, Temmerman M. Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women's health clinics in Nicaragua. Sex Transm Infect 2002;78:204-7.
17. Petry KU, Menton S, Menton M, et al. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Brit J Cancer 2003;88:1570-7.